drugset / Trial / NCT05119426
Effectiveness of a Typhoid Conjugate Vaccine in DRC
Phase 4
Unknown
48000 enrolled
International Vaccine Institute
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo · collabInstitute of Tropical Medicine, Belgium · collabUniversity of Cambridge · collab
NaSingle-groupOpen-labelPrevention
Summary
This is a prospective cohort evaluation of vaccine effectiveness of a single dose of Typbar-TCV® against symptomatic blood culture-confirmed typhoid fever when administered through a mass vaccination campaign to children 9 months to \<16 years of age in Kisantu, DRC.
Timeline
- Start
- 2022-02-11
- Primary completion
- 2024-12
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vi-TT | Vaccine | — | — |